RejuvaCell's Breakthrough Stem Cell Therapy Demonstrates Potential to Revolutionize Treatment for Type-2 Diabetes

Source: RejuvaCell Inc.
Posted: November 29, 2006

Summary:

RejuvaCell Inc., a global leader in adult stem cell therapy for intractable Heart and Vascular diseases, achieves extraordinary advances in the treatment of type-2 diabetes. Over 200 patients treated to date, with 85% of 100 Patients at one year on, maintain significant improvement.